Omeprazole/sodium bicarbonate suspension - Azurity Pharmaceuticals
Alternative Names: KONVOMEP; Sodium bicarbonate/omeprazole suspension - Azurity PharmaceuticalsLatest Information Update: 19 May 2023
At a glance
- Originator Azurity Pharmaceuticals
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Alkalinising agents; Antiulcers; Gastric antisecretories; Small molecules; Sodium compounds
- Mechanism of Action Antacids; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Gastric ulcer; Gastrointestinal haemorrhage